(+)-Alpha-Tocopheryl Succinate

(+)-Alpha-Tocopheryl Succinate

SCHEMBL134422

Cc1c(C)c2c(c(C)c1OC(=O)CCC(=O)O)CC[C@@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)O2

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GSTO1 P78417 2/20 1.00
PTPN1 P18031 1/20 1.00
MEN1 O00255 2/20 0.77
KMT2A Q03164 2/20 0.77
PDE4A P27815 1/20 0.77
PDE3A Q14432 1/20 0.77
PSEN1 P49768 4/20 0.75
TTPA P49638 3/20 0.64
LMNA P02545 3/20 0.64
MAPT P10636 2/20 0.64
GSTP1 P09211 1/20 0.64
USP2 O75604 1/20 0.64
THRB P10828 1/20 0.64
CYP2C9 P11712 1/20 0.64
CYP2C19 P33261 1/20 0.64
NR1I2 O75469 3/20 0.59
ALOX5 P09917 1/20 0.59
PGR P06401 1/20 0.54
AKT1 P31749 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL628454 1.00 GSTO1 (1.00) GSTO1PTPN1MEN1KMT2APDE4A
SCHEMBL21999363 1.00 GSTO1 (1.00) GSTO1PTPN1MEN1KMT2APDE4A
(+)-Alpha-Tocopheryl Succinate SCHEMBL17749239 1.00 GSTO1 (1.00) GSTO1PTPN1MEN1KMT2APDE4A
(+)-Alpha-Tocopheryl Succinate SCHEMBL29409614 1.00 GSTO1 (1.00) GSTO1PTPN1MEN1KMT2APDE4A
(+)-Alpha-Tocopheryl Succinate SCHEMBL29903398 1.00 GSTO1 (1.00) GSTO1PTPN1MEN1KMT2APDE4A
(+)-Alpha-Tocopheryl Succinate SCHEMBL12628147 1.00 GSTO1 (1.00) GSTO1PTPN1MEN1KMT2APDE4A
(+)-Alpha-Tocopheryl Succinate SCHEMBL2162349 1.00 GSTO1 (1.00) GSTO1PTPN1MEN1KMT2APDE4A
SCHEMBL13309644 0.96 GSTO1 (0.93) GSTO1PTPN1MEN1KMT2APDE4A
SCHEMBL12535829 0.96 GSTO1 (0.93) GSTO1PTPN1MEN1KMT2APDE4A
SCHEMBL22199470 0.96 GSTO1 (0.93) GSTO1PTPN1MEN1KMT2APDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2150 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4684779-A1 LIPID NANOSYSTEMS Diversa Technologies S.L. (ES) 2026-01-28 EP claimed
EP-4684002-A2 THYROCYTES AND USES THEREOF Lifenet Health (US) 2026-01-28 EP claimed
WO-2025261731-A1 A SOAP BAR COMPOSITION UNILEVER IP HOLDINGS B.V. (NL) 2025-12-26 WO claimed
EP-4661876-A1 METABOLIC INHIBITORS AND METHODS OF MAKING AND USING THEREOF University of Miami (US) 2025-12-17 EP claimed
US-12491174-B2 Omega-3 compositions and methods relating thereto PHARMAKO BIOTECHNOLOGIES PTY LIMITED (AU) 2025-12-09 US claimed
US-20250367111-A1 DELIVERY OF SUSTAINED LOCAL AND SYSTEMIC IMMUNOMODULATION UNIV NORTHEASTERN (US) 2025-12-04 US claimed
US-12479778-B2 Plant food to enhance the nutritional value of pollen and nectar of plants to attract bees, butterflies and other pollinators MAIWALD DIANE (US) 2025-11-25 US claimed
EP-4181883-B1 GRANULES CONTAINING POSACONAZOLE TIEFENBACHER ALFRED E GMBH & CO KG (DE) 2025-11-19 EP claimed
WO-2025227122-A1 ADIPOSE-SELECTIVE BRANCHED RNA COMPOUNDS UNIVERSITY OF MASSACHUSETTS (US) 2025-10-30 WO claimed
US-12453713-B2 Liquid formulation to treat a corneal tissue VISION ENGINEERING ITALY SRL (IT) 2025-10-28 US claimed
WO-2001017480-A2 METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING URINARY TRACT DISORDERS ANDROSOLUTIONS, INC. (US) 2001-03-15 WO claimed
US-5977158-A Pharmaceutical formulations comprising levormeloxifene compounds NOVO NORDISK A/S (DK) 1999-11-02 US claimed
US-5830505-A MEDICAL LAMINATE HEXAL PHARMA GMBH (DE) 1998-11-03 US claimed
EP-0695177-B1 ACTIVE SUBSTANCE-CONTAINING PLASTER HEXAL AG (DE) 1998-02-18 EP claimed
CN-1169113-A Solubilizing aid for hydrophilic macromolecules CORTECS LTD (GB) 1997-12-31 CN claimed
US-5683711-A TRANSDERMAL DRUG DELIVERY OF ESTROGEN HORMONES HEXAL PHARMA GMBH (DE) 1997-11-04 US claimed
WO-1990010440-A1 COMPOSITION AND METHOD FOR INDUCING TUMOR REGRESSION PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 1990-09-20 WO claimed
US-4873088-A ADRIAMYCIN AND A SECONDARY COMPOUND TO ENHANCE ITS EFFECTIVENESS AND REDUCING TOXICITY; ENTRAPPED IN LIPOSOMES LIPOSOME TECHNOLOGY, INC. (US) 1989-10-10 US claimed
EP-0153955-A1 LIPOSOME DELIVERY METHOD FOR DECREASING THE TOXICITY OF AN ANTITUMOR DRUG HEALTH RESEARCH, INC. (US) 1985-09-11 EP claimed
WO-1985000968-A1 LIPOSOME DELIVERY METHOD FOR DECREASING THE TOXICITY OF AN ANTITUMOR DRUG HEALTH RESEARCH, INC. (US) 1985-03-14 WO claimed